Výsledky vyhledávání - "Maria Laura Ponti"

AISF position paper on liver transplantation and pregnancy

Autor: Anna Alisi, Clara Balsano, Veronica Bernabucci, Annalisa Berzigotti, Maurizia Brunetto, Elisabetta Bugianesi, Patrizia Burra, Vincenza Calvaruso, Elisabetta Cariani, Barbara Coco, Isabelle Colle, Rosina Critelli, Eleonora De Martin, Mariagrazia Del Buono, Isabel Fabregat, Francesca Faillaci, Giovanna Fattovich, Annarosa Floreani, Guadalupe Garcia-Tsao, Chantal Housset, Aimilia Karampatou, Barbara Lei, Alessandra Mangia, Maria Luz Martinez-Chantar, Fabiola Milosa, Filomena Morisco, Paola Nasta, Tomris Ozben, Teresa Pollicino, Maria Laura Ponti, Patrizia Pontisso, Helen Reeves, Maria Rendina, Kryssia Isabel Rodríguez-Castro, Caterina Sagnelli, Giada Sebastiani, Antonella Smedile, Gloria Taliani, Carmen Vandelli, Ester Vanni, Erica Villa, Ranka Vukotic, Anna Linda Zignego, Kryssia Rodríguez-Castro, Maria Guarino, Giuseppe Mazzella

Publikováno v: Digestive and Liver Disease. 48:860-868

After the first successful pregnancy in a liver transplant recipient in 1978, much evidence has accumulated on the course, outcomes and management strategies of pregnancy following liver transplantation. Generally, liver transplantation restores sexu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7d9a55b30cb849558b18d5959ef300ed
https://doi.org/10.1016/j.dld.2016.04.009

Zobrazit plný text záznamu

Impact of the direct-acting antiviral agents (DAAs) on chronic hepatitis C in Sardinian patients with transfusion-dependent Thalassemia major

Autor: Raffaella Origa, Maria Rosaria Casini, Maria Paola Pilia, Roberto Ganga, Carlo Dessì, GianBattista Leoni, Antonietta Zappu, Maria Perra, Roberto Canu, Maddalena Morittu, Maria Loreta Foschini, Federica Comitini, Debora Murgia, Maria Laura Ponti

Publikováno v: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 51(4)

Background and aims Direct antiviral agents (DAAs) have revolutionised the standard of care for the treatment of hepatitis even in patients with hemoglobinopathies. The aim of this study is to show how, thanks to DAAs, HCV infection has been substant

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32bae4da9c4bc65f75f3dcd2271d9aa2
https://pubmed.ncbi.nlm.nih.gov/30691776

Zobrazit plný text záznamu

Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?

Autor: Velia Chiara Di Maio, Valeria Cento, Marianna Aragri, Stefania Paolucci, Teresa Pollicino, Nicola Coppola, Bianca Bruzzone, Valeria Ghisetti, Maurizio Zazzi, Maurizia Brunetto, Ada Bertoli, Silvia Barbaliscia, Silvia Galli, William Gennari, Fausto Baldanti, Giovanni Raimondo, Carlo Federico Perno, Francesca Ceccherini-Silberstein, Pietro Andreone, Massimo Andreoni, Mario Angelico, Sergio Babudieri, Giorgio Barbarini, Vincenzo Boccaccio, Lucio Boglione, Matteo Bolis, Stefano Bonora, Vanni Borghi, Giuseppina Brancaccio, Savino Bruno, Pierluigi Cacciatore, Vincenza Calvaruso, Nicola Caporaso, Antonio Ciaccio, Alessia Ciancio, Piero Colombatto, Raffaele Cozzolongo, Antonio Craxì, Cecilia D'Ambrosio, Gabriella D'Ettorre, Andrea De Luca, Antonio Di Biagio, Giovanni Di Perri, Simona Francioso, Giovanni Battista Gaeta, Alessia Giorgini, Antonio Grieco, Guido Gubertini, Roberto Gulminetti, Lara Lambiase, Ilaria Lenci, Miriam Lichtner, Ivana Maida, Simona Marenco, Letizia Marinaro, Renato Maserati, Chiara Masetti, Michela Melis, Elisa Meregalli, Valeria Micheli, Filomena Morisco, Fosca Niero, Laura Ambra Nicolini, Valeria Pace Palitti, Maurizio Paoloni, Giustino Parruti, Caterina Pasquazzi, Adriano Pellicelli, Ennio Polilli, Maria Laura Ponti, Massimo Puoti, Maria Rendina, Giuliano Rizzardini, Barbara Rossetti, Tina Ruggiero, Vincenzo Sangiovanni, Mario Starace, Laura Sticchi, Pierluigi Tarquini, Pierluigi Toniutto, Vincenzo Vullo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5feb34a815fb252bfeeb7d412c134bae
http://hdl.handle.net/11573/1552372

Zobrazit plný text záznamu

Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies

Autor: Lucia De Franceschi, Antonio Piga, Domenico Giuseppe D'Ascola, A. Lanza, Vito Di Marco, Valeria Pinto, Aldo Filosa, Maria Laura Ponti, Antonino Picciotto, Giorgio Maria Saracco, Maria Domenica Cappellini, Barbara Gianesin, Rosamaria Rosso, Gian Luca Forni, Paolo Rigano, Raffaella Origa, Roberta D'Ambrosio, Salvatore Madonia, Immacolata Tartaglione

Progression of liver fibrosis in patients with hemoglobinopathies is strongly related to the severity of iron overload and the presence of chronic hepatitis C virus (HCV) infection. Effective iron chelation therapy and HCV infection eradication may p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::616f47075e314c0ae09b329067db932b
http://hdl.handle.net/10447/253869

Zobrazit plný text záznamu

SLOW ACHIEVEMENT OF HCV-RNA UNDETECTABILITY IN CIRRHOTIC PATIENTS TREATED WITH SOFOSBUVIR plus RIBAVIRIN: POSSIBLE CLINICAL IMPLICATIONS IN THE LIVER TRANSPLANT LIST MANAGEMENT

Publikováno v: Transplant international 28 (2015): 22–23.
info:cnr-pdr/source/autori:Sforza, Daniele; Lenci, Ilaria; Manuelli, Matteo; Cento, Valeria; Rendina, Maria; Maria, Francesca Donato; Martina, Milana; Marianna, Aragri; Velia, Chiara Di Maio; Amal, Abedrabbo; Federico, Malinverno; Sara, Monico; Maria, Laura Ponti; Roberta, Canu; Roberto, Ganga; Milanesi, Luciano; Di Leo, Alfredo; Perno, Carlo Federico; Ceccherini-Silberstein, Francesca; Colombo, Massimo; Angelico, Mario; Tisone, Giuseppe/titolo:SLOW ACHIEVEMENT OF HCV-RNA UNDETECTABILITY IN CIRRHOTIC PATIENTS TREATED WITH SOFOSBUVIR plus RIBAVIRIN: POSSIBLE CLINICAL IMPLICATIONS IN THE LIVER TRANSPLANT LIST MANAGEMENT/doi:/rivista:Transplant international/anno:2015/pagina_da:22/pagina_a:23/intervallo_pagine:22–23/volume:28

Sofosbuvir (SOF) treatment ± ribavirin (RBV) prior to LT has the potential to change the HCV recurrence after Liver Transplantation (LT). This approach has been reported to avoid graft reinfection in compensated patients with hepatocellular carcinom

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::5f58904404566901e838ed0a7393e0ac
http://www.cnr.it/prodotto/i/361408

Zobrazit plný text záznamu

Slow achievement of HCV-RNA undetectability in cirrhotic patients treated with sofosbuvir+ribavirin: possible clinical implications in the liver transplant list management

Publikováno v: 48th A.I.S.F.-Italian Association for the Study of the Liver, pp. 29–30, Roma, 2015
info:cnr-pdr/source/autori:I. Lenci, V. Cento, M. Rendina, M.F. Donato, M. Milana, D. Sforza, M. Manuelli, M. Aragri, V.C. Di Maio, A. Abedrabbo, A. Castellaneta, F. Malinverno, S. Monico, M.L. Ponti, R. Canu, R. Ganga, R. Alfieri, L. Milanesi, A. Di Leo, G. Tisone, C.F. Perno, F. Ceccherini-Silberstein, M. Colombo, M. Angelico/congresso_nome:48th A.I.S.F.-Italian Association for the Study of the Liver/congresso_luogo:Roma/congresso_data:2015/anno:2015/pagina_da:29/pagina_a:30/intervallo_pagine:29–30

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dfe0677d475a76020acd9244bd54c83

Zobrazit plný text záznamu

A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: The TT4 randomized trial

Background Rapid and early virological responses to peginterferon-alpha and ribavirin are predictive of sustained virological response (SVR) in hepatitis C virus (HCV) infection. We aimed at finding a simple rule to determine the shortest duration of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ea54a08fcc659d9643c454130ab5a4c
http://hdl.handle.net/11573/559645

Zobrazit plný text záznamu

A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B

Autor: Franco Bandiera, Lorenzo Nosotti, Orazio Sorbello, Luigi Demelia, Paola Piccolo, Ilaria Lenci, M.R. Piras, Fabio Iacomi, Giorgio Antonucci, T. Mari, Mario Angelico, Maria Laura Ponti, Adriano De Santis

Background Pegylated interferon (PEG-IFN)-α monotherapy is the current standard of care for short-term antiviral treatment of hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB). We aimed to assess the safety and efficacy of PEG-IFN-α

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c995e93a36809add7b5684ca6db3b9a0
http://hdl.handle.net/2108/66313

Zobrazit plný text záznamu

Transient elastography in patients with chronic autoimmune hepatitis: is a good tool in evaluation of hepatic fibrosis?

Publikováno v: Digestive and Liver Disease. 47:e64

S. Onali 1,5, S. Cappellini1,5, G. Serra1,5, T. Zolfino2,5, D. Murgia3,5, M.L. Ponti3,5, C. Balestrieri 1,5, M. Conti1,5, O. Sorbello4,5, A. Civolani4,5, M. Casale1,5, S. Casu1,5, F. Figorilli 1,5, M.C. Pasetto1,5, A. Gaspardini1,5, L. Secci1,5, C. S

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b623141d47f7fb83f46bfe131e807f2f
https://doi.org/10.1016/j.dld.2015.01.139

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání